Cargando…
Genetic validation of neurokinin 3 receptor antagonists for ischemic heart disease prevention in men – A one-sample Mendelian randomization study
BACKGROUND: Ischemic heart disease (IHD) is a leading cause of mortality, particularly for men. Few interventions have focused on protecting specifically men. Emerging evidence may implicate testosterone. Neurokinin 3 receptor (NK3R) antagonists, an existing class of drugs being considered as treatm...
Autor principal: | Schooling, C.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885564/ https://www.ncbi.nlm.nih.gov/pubmed/35231698 http://dx.doi.org/10.1016/j.ebiom.2022.103901 |
Ejemplares similares
-
Reproduction and longevity: A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease
por: Schooling, C.M., et al.
Publicado: (2019) -
Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
por: Zhao, Jie V., et al.
Publicado: (2021) -
Investigating pleiotropic effects of statins on ischemic heart disease in the UK Biobank using Mendelian randomisation
por: Schooling, CM, et al.
Publicado: (2020) -
Neurokinin 1 Receptor Antagonists for Pruritus
por: Alam, Majid, et al.
Publicado: (2021) -
Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men
por: Anderson, Richard A, et al.
Publicado: (2020)